| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.15 | 0.6 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |